Prediabetes and risk of diabetes and associated complications
- 1 September 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 19 (5) , 394-399
Abstract
Purpose of review The purpose of this review is to summarize the distinct metabolic and pathophysiologic phenotype of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) and the subsequent clinical implications with regard to future type 2 diabetes mellitus (T2DM) and cardiovascular risk. Recent findings Both IFG and IGT manifest the two core defects of T2DM, that is, insulin resistance and β-cell dysfunction. However, the site of insulin resistance and shape of β-cell dysfunction differ. These distinct metabolic and pathophysiologic phenotypes explain the greater cardiovascular disease (CVD) risk associated with an increase in the 2-h plasma glucose concentration, that is, IGT compared with an increase in the fasting plasma glucose (FPG) concentration, that is, IFG. Moreover, the increase in future T2DM risk in IFG study participants is, at least in part, explained by the strong correlation between the increase in FPG and the increase in 2-h plasma glucose concentration. Summary Last, recent studies have reported the presence of diabetic microvascular complications, that is, retinopathy and neuropathy, at the IGT stage. Thus, a glucose load (e.g. oral glucose tolerance test) is required in study participants with elevated FPG concentration to accurately assess their future risk for T2DM, as well as their risk for CVD to identify the subgroup of IFG who are at greater risk and subject them to an intervention program to decrease their future T2DM and CVD risk.Keywords
This publication has 18 references indexed in Scilit:
- Postchallenge Hyperglycemia Is Positively Associated With Diabetic PolyneuropathyDiabetes Care, 2012
- Basal Insulin and Cardiovascular and Other Outcomes in DysglycemiaNew England Journal of Medicine, 2012
- Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose ToleranceDiabetes, 2012
- Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting GlucoseThe American Journal of Cardiology, 2011
- The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetesDiabetes/Metabolism Research and Reviews, 2010
- Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma GlucoseDiabetes Care, 2009
- Retinopathy in subjects with impaired fasting glucose: the NANSY‐Eye baseline reportDiabetes, Obesity and Metabolism, 2008
- Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma GlucoseDiabetes Care, 2006
- Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and interventionDiabetic Medicine, 2002
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999